Page last updated: 2024-08-24

plerixafor and Neoplasms, Germ Cell and Embryonal

plerixafor has been researched along with Neoplasms, Germ Cell and Embryonal in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Cassano, A; Chiusolo, P; Corbingi, A; Di Salvatore, M; Massini, G; Metafuni, E; Piccirillo, N; Putzulu, R; Rossi, E; Schinzari, G; Sica, S; Zini, G1
Carbone, A; De Blasio, A; Ortu La Barbera, E; Pacilli, M; Papa, A; Rossi, L; Salvatori, R; Tomao, S; Zaccarelli, E; Zappone, E1
Daphne O'Hara, VJ; Karr, AH; Kiel, PJ; Srivastava, S1
Athanasopoulos, A; Daladimos, T; Dimitriadis, G; Gekas, C; Kosmas, C; Lydakis, D; Magiorkinis, E; Miltiadous, C; Mylonakis, N; Zilakos, M; Ziras, N1
Dimitriadis, GK; Kosmas, C; Miltiadous, C; Roditis, P1
Bogner, C; Bokemeyer, C; Fiedler, W; Frickhofen, N; Hübel, K; Isernhagen, J; Kilic, N; Kobold, S1
Abdel-Rahman, FA; Tuffaha, H1
Calandra, GC; Holman, P; Horwitz, ME; Libby, E; Long, G; Schriber, JR1
Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Mohty, M; Selleslag, D; Worel, N1

Trials

2 trial(s) available for plerixafor and Neoplasms, Germ Cell and Embryonal

ArticleYear
Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.
    Bone marrow transplantation, 2011, Volume: 46, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Combined Modality Therapy; Compassionate Use Trials; Cyclams; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Seminoma; Testicular Neoplasms; Ultrasonography; Young Adult

2011
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors.
    Bone marrow transplantation, 2012, Volume: 47, Issue:10

    Topics: Adult; Anti-HIV Agents; Antigens, CD34; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Time Factors; Transplantation, Autologous

2012

Other Studies

7 other study(ies) available for plerixafor and Neoplasms, Germ Cell and Embryonal

ArticleYear
Successful "on-demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors.
    Journal of clinical apheresis, 2022, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Benzylamines; Blood Component Removal; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Peripheral Blood Stem Cells; Retrospective Studies; Transplantation, Autologous; Young Adult

2022
Plerixafor and autologous stem cell transplantation: impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy.
    Anti-cancer drugs, 2013, Volume: 24, Issue:6

    Topics: Adult; Antineoplastic Agents; Benzylamines; Cyclams; Cyclophosphamide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Male; Neoplasms, Germ Cell and Embryonal; Receptors, CXCR4; Stem Cell Transplantation; Testicular Neoplasms

2013
Experience with plerixafor for hematopoietic cell mobilization in nine patients with germ cell tumors.
    Pharmacotherapy, 2014, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Benzylamines; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Young Adult

2014
Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumo
    Anti-cancer drugs, 2014, Volume: 25, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cisplatin; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Transplantation, Autologous; Young Adult

2014
Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation: report
    Anti-cancer drugs, 2017, Volume: 28, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Carboplatin; Cyclams; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Thiotepa

2017
Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Antineoplastic Agents; Benzylamines; Carboplatin; Cyclams; Etoposide; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous

2010
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.
    Transfusion, 2012, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antineoplastic Agents; Benzylamines; Blood Component Removal; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclams; Europe; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Sarcoma, Ewing; Stem Cell Transplantation; Wiskott-Aldrich Syndrome; Young Adult

2012